Hugel, Inc., a leading global medical aesthetics company publicly traded in South Korea, has unveiled a new face for its corporate and brand campaigns, launching a new advertising initiative in Korea featuring acting star Ji Chang-wook. Renowned for his strong acting credentials, trustworthy image, and broad public appeal, Ji will front the company’s latest integrated campaign.
The new campaign consists of three advertising films designed to strengthen Hugel’s corporate value and competitive positioning; raise awareness of the company’s BYRYZN Skin Booster HA, and promote The Chaeum dermal filler portfolio. By organically connecting the three campaign films, Hugel aims to highlight its global competitiveness and product portfolio.
The corporate campaign focuses on the core message, “Hugel leading the way in K-aesthetics,” highlighting its global presence. Hugel is the first and only Korean company — and the fourth company worldwide — to have entered all three major botulinum toxin markets: the U.S., China, and Europe.
The brand campaign films deliver a sophisticated portrayal of the wrinkle-improving benefits of The Chaeum and BYRYZN Skin Booster HA, both formulated with Hugel’s high-purity hyaluronic acid technology. Backed by proven product quality and technology, Hugel provides integrated aesthetic solutions to medical professionals and consumers around the world.
Beginning on May 18, the new campaign will roll out across outdoor advertising locations in 27 key commercial districts nationwide — including Gangnam and Samseong areas — as well as major online platforms and over-the-top channels.
“Medical aesthetic technologies and trends originating in Korea are increasingly becoming an important benchmark for the global aesthetics industry,” said Daniel Chang, Korea CEO of Hugel. “Through the new campaign, we aim to further strengthen Hugel’s position as a leading Korean aesthetics company and continue demonstrating its growing corporate value.”
About Hugel
Established in 2001, Hugel is a global leader in medical aesthetics, specializing in the production of injectables for skin rejuvenation, including botulinum toxin, hyaluronic acid fillers, and skin boosters, as well as absorbable sutures and cosmetic products. With a proven track record of safety and quality, Hugel is deeply committed to advancing the industry through robust medical affairs, comprehensive training programs, and dynamic industry forums.
Over the past 20 years, the company has built a presence in approximately 70 countries and operates nine global subsidiaries across the U.S., Australia, Canada, Taiwan, China, Hong Kong, Singapore, and Thailand. Leveraging strong industry momentum, Hugel is well-positioned for continued growth and market expansion worldwide.
(Photo caption) Hugel names Ji Chang-wook as its new corporate and brand model
